WS 2015_sponsor logo 3
“Bispecific Antibodies and
Antibody-drug Conjugates”
Friday 16 October 2015
Ablynx, Ghent, Belgium

8:30-9:00 Coffee
9:00-9:10 Welcome
Morning session: Lectures
9:10-9:55 Non-clinical considerations in the development of bispecific antibodies in inflammatory diseases
B. Schlereth, Covagen, Germany
9:55-10:40 Nonclinical assessment of Bispecific T cell-engaging Antibodies (BiTE®) and their transition into the clinic for anti-cancer therapy
B Rattel, Amgen/Micromet, Germany
10:40-11:10 Coffee break
11:10-11:40 Bioanalytical considerations for bispecific antibodies and antibody-drug conjugates
TBD
11:40-12:25 Nonclinical safety perspective on the development of Antibody-Drug-Conjugates
D van den Dobbelsteen, Synthon, The Netherlands
12:25-13:30 Lunch and networking
Afternoon session: Case studies analysis
13:30-13:45 Introduction to breakout sessions
13:45-14:50 Breakout sessions
14:50-15:05 Coffee break
15:05-16:20 Case study reporting and discussion
16:20-16:30 Concluding remarks

Click here to register

Organizing Committee:
Judith Baumeister (Ablynx), Micaela Damsten, Frédérique Delannois and Lawrence Segal (GSK Vaccines), Miek Desmidt, Ad Knaapen and Ilham Smyej (Johnson & Johnson), Annick Cauvin and Miranda Cornet (UCB Pharma)

To download the program, the itinerary or the list of recommended hotels, please use the attachments below:

Programme Workshop Safety Assessment Biopharm 2015

Route description Ablynx

Address Ablynx & recommended hotels Gent